Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00420849 is registered in ClinicalTrials.gov with Celgene Corporation as lead sponsor.

NCT NCT00420849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00420849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Lead sponsor
Celgene Corporation
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
November 30, 2009
Enrollment
587 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma